
This study describes the possible poor treatment response (PPTR) process. It evaluates whether the goals of minimizing bias in efficacy endpoint assessment and attaining relevant data to determine outcomes for all participants were achieved. Among 2,343 participants with culture-confirmed drug-susceptible TB, 454 individuals (19.4%) had a total of 534 individual PPTR events, of which 76.6% were microbiological. Standardized methodologies, such as our PPTR approach, could facilitate unbiased efficacy outcome determinations, improve discrimination between outcomes that are related and unrelated to regimen efficacy, and enhance the ability to conduct pooled analyses of contemporary trials.
Like
Save
Share